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Abstract Spindle cell oncocytoma (SCO) is a rare, non-
adenomatous tumor originating from the anterior pituitary
gland. Composed of fusiform, mitochondrion-rich cells
sharing several immunophenotypic and ultrastructural
properties with folliculo-stellate cells (FSC), SCO has been
proposed to represent a neoplastic counterpart of the latter.
To date, however, SCO has failed to meet one criterion
commonly used in histological-based taxonomy and
diagnostics; that of recapitulating any of FSCs’ morpho-
logically defined developmental or physiological states. We
describe a unique example of SCO wherein a conventional
fascicular texture was seen coexisting with and organically
merging into follicle-like arrangements. The sellar tumor of
2.7 9 2.6 9 2.5 cm was transphenoidally resected from a
55-year old female. Preoperative magnetic resonance
imaging indicated an isointense, contrast enhancing mass
with suprasellar extension. Histology showed multiple
rudimentary to well-formed, follicle-like cavities on a
classical spindle cell background; while all the participating
cells exhibited an SCO immunophenotype, including posi-
tivity for S100 protein, vimentin, EMA, Bcl-2, and TTF-1,
as well as staining with the antimitochondrial antibody
113-1. Conversely no expression of GFAP, follicular-epi-
thelial cytokeratin, carcinoembryonic antigen, or anterior
pituitary hormones was detected. Ultrastructurally, tumor
cells facing follicular lumina displayed organelles of epi-
thelial specialization, in particular surface microvilli and
apical tight junctions. This constellation is felt to be remi-
niscent of FSCs’ metaplastic transition to follicular
epithelium, as observed during embryonic development and
physiological renewal of the hormone-secreting paren-
chyma. Such finding is apt to being read as a supporting
argument for SCO’s descent from the FSC lineage.
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Introduction
Spindle cell oncocytoma (SCO) is an uncommon adeno-
hypophysial tumor composed of mitochondrion-rich,
fusiform cells, with a characteristic immunophenotype and
no demonstrable hormonal activity [9, 22]. In the context
of its exclusive predilection for the anterior pituitary, the
immunoprofile and ultrastructure of SCO have been con-
strued to indicate its being a neoplasm of folliculo-stellate
cells (FSCs).
In fact, SCO cells bear little microscopic resemblance to
native FSCs; nor does the fairly monotonous morphology
of the hitherto known examples of SCO seem to reflect any
of FSCs’ functional-related phenotypic variations [1, 12].
Indeed, reported nonstandard examples of SCO tend to
document features of aggressive behavior rather than
any significant departure from its conventional histology
[6–8, 16].
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Involvement with the embryogenesis and the life cycle of
follicular-epithelial cells probably represents the most readily
observable facet of FSCs’ functions [2, 12]. Specifically, a
subset of FSCs have been shown to directly contribute to the
renewal of endocrine parenchyma by undergoing epithelial
transformation. To date, only one recent report by Horvath
et al. [13] revealed ultrastructural evidence of ‘‘quasi-follic-
ular’’ organelles in two SCO-like tumors; these invite reading
as the ‘‘missing link’’ in the argument for SCOs’ actually
sharing some of FSCs’ dynamic properties.
In the following, we describe an hitherto not documented
phenomenon of overtly follicle-like differentiation within an
otherwise classical SCO. This pattern is felt to recapitulate
FSCs’ potential to participate in follicular cytogenesis.
Case report
Clinical history
The 55-year old woman was discovered to harbor a sellar
space-occupying lesion while being medically prepared for
hip joint replacement surgery. Her past medical history had
included type 2 diabetes mellitus, dyslipidemia, and arterial
hypertension, as well as the patient’s reporting ‘‘estrogen
therapy in childhood for short stature’’. Neurological exami-
nation, including perimetric visual field assessment, was
unremarkable. Endocrinologic laboratory testing, on the other
hand, indicated panhypopituitarism without evidence of dia-
betes insipidus or secondary hyperprolactinemia. Cranial
magnetic resonance imaging (MRI) revealed a voluminous
yet noninvasive intra- and suprasellar tumor of 2.7 9 2.6 9
2.5 cm (Fig. 1). On a presumptive diagnosis of nonfunction-
ing pituitary adenoma, the lesion was totally resected via
transnasal-transphenoidal approach. The patient made an
uneventful recovery, and has been discharged on hormonal
substitution therapy.
Materials and methods
The surgical specimen comprised 11 tissue fragments of
0.1–0.6 cm diameter each, totalling 1.8 9 0.8 9 0.3 cm.
After overnight fixation in 10% buffered formalin, the
tissue block was routinely processed to paraffin, and 3 lm
thick serial sections stained with hematoxylin and eosin
(H.E.), Gomori’s silver (Ag) impregnation for reticulin,
and periodic acid-Schiff’s reagent (PAS). Immunohisto-
chemistry was performed with the following panel of
antibodies: S100 protein (polyclonal; Dako, Glostrup,
Denmark), Bcl-2 (clone 124; Dako), epithelial membrane
antigen—EMA (clone E29,; Dako), carcinoembryonic
antigen—CEA (clone II-7; Dako), thyroid transcription
factor 1—TTF-1 (clone SPT24; Leica Biosystems, New-
castle-upon-Tyne, UK), vimentin (clone Vim 3B4; Dako),
mitochondrial antigen (clone 113-1; BioGenex, San
Ramon, CA, USA), cytokeratin 8 (clone CAM5.2; BD
Biosciences, San Jose, CA, USA), synaptophysin (clone
27G12; Leica Biosystems), chromogranin A (polyclonal;
Dako); NCAM (clone 123C3; Sanbio, Uden, The Nether-
lands), GFAP (clone 6F2; Dako, Glostrup, Denmark),
smooth muscle actin (clone 1A4; Sigma, St. Louis, MO,
USA), CD34 (clone QBend/10; Dako), Ki-67 (clone MIB1;
Dako), as well as PRL, GH, ACTH, TSH, LH, FSH, and
a-subunit. The specifications for the anterior pituitary
hormones and details of the immunohistochemical proto-
col used have been documented previously [26]. Slides
were developed with polymer-bound horseradish peroxi-
dase (Envision?; Dako) and 3,30-diaminobenzidine as
chromogen.
For ultrastructural study, representative tissue fragments
were retrieved from the paraffin block, postfixed in glu-
taraldehyde and transferred to Spurr’s Resin (SERVA—
Heidelberg, Germany) for ultrathin sectioning. Grids were
contrasted with uranyl acetate and lead citrate, and viewed
in a Zeiss E10 transmission electron microscope.
Fig. 1 Preoperative imaging findings. Sagittal T1-weighted (a) and
post-Gadolinium (b) sequences to show well circumscribed, isoin-
tense, homogeneously enhancing mass with ballooning of the sella
and suprasellar extension. Semilunar cleavage plan (arrow) suggests
minimal residual anterior pituitary parenchyma. Frontal T2-weighted
sequence (c) indicates lack of involvement of carotid sinuses
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Pathological findings
Light microscopy revealed a moderately cellular solid
neoplasm, wherein fusiform to plump roundish cells tended
to segregate along a biphasic architectural pattern (Fig. 2a).
The prevailing component consisted of compact fasci-
cles with sweeping or rudimentarily intersecting profiles,
the individual cells variously exhibiting chromophobic
to granular-eosinophilic, and PAS-negative cytoplasm
(Fig. 2b). The second moiety involved a scatter of follicle-
like lumina encircled by radially arranged tumor cells
(Fig. 2c). These cavities tended to be devoid of any
secretion (Fig. 2d); nor did their lining cells rest on a
basement membrane (Fig. 2e). In addition to such discrete
foci, there were several transitional areas of follicle-like
differentiation, including dehiscences of tumor cells along
slit-like channels or small nests centered around a punctate
vacuole (Fig. 2f). Largely devoid of atypia, the majority of
tumor cell nuclei had round to ovoid contours. Mitotic activity
was absent, as were microvascular proliferation and necrosis.
Alongside the tumor, the material also contained a sizable
fragment of adenohypophysial parenchyma—which was
taken advantage of as an internal control to assess the quality
of the immunostains described below. Residues of neurohy-
pophysis were not identified.
Regardless of architectural variations, the tumor cells
showed coexpression of S100 protein, vimentin, Bcl-2, and
TTF-1, along with granular staining for the antimitoc-
hondrial antibody 113-1 (Fig. 2g–k). Staining for EMA
tended to produce a rather faint cytoplasmic signal; con-
spicuously, however, the apical surface of tumor cells
along the follicle-like lumina was intensely decorated
(Fig. 2l). Conversely, no juxtanuclear ‘‘dots’’ were detec-
ted. Throughout the tumor, immunoreactions for CAM5.2,
CEA, GFAP, CD56/NCAM, CD34, a-SMA, chromogranin
A, as well as those for anterior pituitary hormones yielded
negative results. Interestingly, a small minority of tumor
cells amidst the conventional fusiform population featured
Golgi-pattern positivity for synaptophysin (Fig. 2m). There
were an average of 1.5–2% MIB1-immunoreactive nuclei.
Despite poor preservation of ultrastructure, organelles
indicative of epithelial specialization were readily identi-
fied in lumen-forming tumor cells by electron microscopy
(Fig. 2n–p). On account of these findings, a diagnosis of
SCO (WHO grade I) was issued along with a comment
regarding the nonstandard aspects of its histology.
Discussion
We observed a novel, previously not documented pattern of
follicle-like differentiation in SCO. Although such con-
stellation may seem to contradict the definition of SCO as a
non-epithelial tumor, both the basic texture and the
immunophenotype of the present lesion do comply with
those of ‘‘classical’’ SCO [6–9, 11, 16, 22]. These include
mitochondrion-rich elongated cells, which coexpress S100
protein, vimentin, and EMA; while being largely devoid of
either follicular-epithelial or glial qualities, as reflected by
their reluctance to staining with cytokeratins or GFAP.
Lack of neurosecretory phenotype, including pituitary
hormones, has been regarded implicit to diagnosis, as well.
Moreover, with the recent demonstration of nuclear TTF-1
expression by SCO, its histogenesis has been put into a
developmentally meaningful context [17].
While none of the above markers is specific, their
coexpression on an appropriate histological background
will distinguish SCO from its look-alikes.
Conversely, the unexpected follicle-like motive seen in
our case is apt to ruling in a few differential diagnostic
alternatives that call for systematic exclusion.
Secretory meningioma regularly includes a spindle cell
component, and may indeed exhibit triple coexpression of
EMA, vimentin, and S100 protein [4]. In addition, how-
ever, its periluminal cells are conspicuously positive for
cytokeratins and CEA—a finding not present in the folli-
cle-like structures observed by us. Moreover, the latter
appeared ‘‘empty’’ rather than containing eosinophilic
colloid as seen in secretory meningioma. It is of anecdotal
interest to note that the first case description of a pituitary
tumor of purported FSC origin (see below) was precisely
challenged by the alternative of secretory meningioma [28,
31].
Schwannian tumors may also occasionally bring forth
pseudoglandular clefts as well as true heterologous glan-
dular differentiation—although the latter phenomenon
almost exclusively arises in high-grade lesions (i.e.,
MPNST) [21, 30]. While the rare actual examples of sellar
region Schwannoma on record are all of conventional type
[18], at least one published report on benign glandular
Schwannoma affecting a cranial nerve lends some plau-
siblity to such differential diagnosis [5].
Salivary gland-type tumors of the pituitary are particu-
larly apt to generating a differential diagnostic dilemma
[10]. Indeed, their versatile morphology often encompasses
both spindle cell and oncocytic patterns; and expression of
S100 protein, EMA, and GFAP may be part of their im-
munoprofile, as well. Nevertheless, whether on a spindle
cell or oncocytic background, the adenomatous element of
salivary gland tumors invariably involves cytokeratin
expressing dimorphic epithelia wherein basal cells exhibit
a myoepithelial phenotype.
The rare sellar ependymomas represent yet another
differential diagnostically appealing variation on the
biphasic architectural theme [24]. Indeed, the radial arrays
of tumor cells along round to slit-like lumina in our case
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readily call to mind ependymal tubules or contorted
pseudoventricular cavities. Awareness of the recently
described occurrence of oncocytic change in ependymoma
may further induce to such interpretation [27]. Besides
lacking GFAP immunoreactivity, the follicle-forming SCO
described here did not show either the distinctive dot-like
EMA staining of ependymoma, or its ultrastructural cor-
relate [4]. While the thought-provoking hypothesis of sellar
ependymoma being a variant of pituicytoma—therefore
potentially related to SCO as well [3, 25]—has been put
forward by Scheithauer et al., results of immunohisto-
chemistry for TTF-1 have not been provided by these
authors.
A numerically variable side population of FSCs—the
presumed ancestors of SCO—have been known to regu-
larly complement pituitary adenomas, as well [14, 29]. Of
note, the designation ‘‘folliculo-stellate tumor’’ is being
used by some authors as an interpretative shortcut to refer
to SCO [7, 11].
Historically, the earliest mention of FSCs as the pre-
vailing neoplastic element has been made by Yagishita
et al. [31]. Epithelial rather than fusiform in texture, the
tumor described therein also included conspicuous
mucous-filled acini.
In a series by Iwaki et al. [14] one hormonally inactive
tumor out of 40 pituitary adenomas tested for the immu-
noexpression of S100 protein and GFAP was felt to be
composed mostly by tumor cells of FSC origin. As
depicted in Fig. 3 of that paper, these exhibited overtly
epithelial qualities, as well as prominent follicle formation.
Intriguingly, periluminal cells were explicitely described as
being ‘‘rich in mitochondria’’ (Fig. 4 therein). Lack of
reported data on EMA and cytokeratin staining, unfortu-
nately, does not allow for further potential analogies with
our case to be explored.
Of late, Min et al. [19] reported on a pediatric example
of morphologically complex silent corticotroph cell ade-
noma, wherein a conventional endocrine-type epithelium
was punctuated by mucinous glands. The latter, in turn,
were felt to be intimately commingling with and recipro-
cally merging into what the authors interpreted as FSCs. It
is suggested that these be regarded as neoplastic in nature,
ones illustrating a process of ‘‘retrodifferentiation’’ of
Rathke’s pouch epithelium into hormone-secreting cells
via FSCs. In fact, follicular differentiation involving an
amphicrine phenotype is by no means exceptional in
pituitary adenomas, the best known examples being pro-
lactinomas with transitional architecture [15, 20].
Nevertheless, the issue of FSCs’ actual impact on the
morphogenesis of such nearly physiological, organoid
structures probably cannot be addressed adequately by
direct inference from histology.
In our case, the very imperfection of the follicle-forming
attempt is felt to represent a considerable advantage. While
the tumor cells along the lumina displayed obvious hall-
marks of epithelial commitment, in particular baso-apical
polarization (as evidenced by surface asymmetry of EMA
staining), they were still recognizable as SCO by virtue of
both their conventional S100?/vimentin?/Bcl-2?/TTF-1?/
CAM5.2- immunoprofile, as well as ultrastructurally. A
novel finding, Golgi-pattern positivity for synaptophysin in
a small minority of tumor cells additionally invites reading
as an indice of emerging phenotypical switch to adenohy-
pophysial epithelium.
A recent account on electron microscopic evidence of
hybrid FSC/follicular-epithelial organelles in two SCO-like
pituitary tumors by Horvath et al. probably represents what
comes closest to our findings [13]. Indeed, the villous
microlumina observed therein quite exactly anticipate the
elementary ultrastructural traits of the follicle-like com-
ponent in the present report. Of particular interest is the
demonstration of neurosecretory granules in case 2 of
Horvath et al.—which is apt to indirectly corroborating the
relevance of focal synaptophysin immunostaining seen by
us. We strongly agree with the authors’ claim that such
morphological peculiarities be regarded as a replica of
FSCs’ plasticity as an epithelial precursor during both
Fig. 2 Histology, immunophenotype, and ultrastructure of follicle-
forming SCO. Low power view of a representative fragment to show
solid architecture punctuated by follicle-like cavities. Overall eosin-
ophilic hue of specimen (a). The lesion’s conventional component
consists of fascicles of spindle cells (b). Well-formed follicle-like
structures involve cuboidal cells which tend to merge into their
regular SCO neighborhood (c). Lumina are either optically lucent or
only contain transudate-like PAS negative fluid (d). Follicle-lining
cells consistently lack a circumferential basement membrane (e).
Dehiscence-like spaces (f) and microlumina (inset: arrow) may
represent intermediate stages of follicle-like differentiation. Irrespec-
tive of architectural variations, tumor cells consistently express
traditional immunomarkers of SCO (g through j). Mitochondrial
immunostaining labels spindle cells and the follicles’ lining alike (k).
Polarity of cells facing lumina is revealed by EMA staining along
their apical surface (l). Inset (i) reveals similarity to staining pattern of
adenohypophysial follicles in nontumorous anterior pituitary gland.
Lack of immunoreactivity for low molecular weight cytokeratin (ii)
helps exclude residual pituitary gland parenchyma that would have
been merely overrun by tumor. Golgi-pattern signal for synaptophysin
in a small minority of tumor cells suggests an emerging neuroendo-
crine phenotype (m). Ultrastructurally, spindle cells are replete with
mitochondria in the conventional SCO component (n). A significant
part of mitochondria are autolytic; their actual density is readily
apparent in some better preserved areas (inset). Cells engaged in
follicle formation (o) display epithelial surface microvilli (arrows)
and junctions by terminal bars (arrowheads). Microlumina (p) contain
amorphous material, plump microvilli (inset), as well as an occasional
cilium (asterisk). Signet ring-like indentation of nucleus (lower right
corner) and desmosomal contact between cells (arrowheads). Micro-
photographs a–c and f represent H.E. stained slides. Original
magnifications: a 609; b 1009; c 4009; d–m 2009; scales for n–
p are indicated by bars
b
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adenohypophysial development and follicular renewal in
the adult pituitary. For the sake of completeness, mention
be made of a unique example of ‘‘pituitary blastoma’’
recently reported by Scheithauer et al. [23]. Possibly mal-
developmental in origin, with its architecture reminiscent
of the pituitary gland at gestational age 10—12 weeks,
FSCs were not felt to significantly participate in the pro-
liferative compartment of this tumor.
In conclusion, it is tempting to regard the above example
of follicle-like differentiation as one additional piece of
morphologic evidence linking SCO to the FSC lineage.
Acknowledgments We wish to thank Ms. Mirjam Janzi for the
histotechnical handling of the material. The immunohistochemical
reactions referred to in this report have been executed by Mrs. Mi-
caela Gu¨del, Christine Steffen, and Ellen Lanz. Processing for
electron microscopy was done by Mrs. Isabelle Estella. Referencing
has been assisted by Mrs. Sibylle Graf and Ire`ne Marconi-Geiser.
References
1. Allaerts W, Vankelecom H (2005) History and perspectives of
pituitary folliculo-stellate cell research. Eur J Endocrinol
153:1–12
2. Asa SL, Kovacs K, Laszlo FA, Domokos I, Ezrin C (1988)
Human fetal adenohypophysis: electron microscopic and ultra-
structural immunocytochemical analysis. Neuroendocrinology
48:423–431
3. Brat DJ, Scheithauer BW, Staugaitis SM, Holtzman RNN, Morgello
S, Burger PC (2000) Pituicytoma. A distinctive low-grade glioma
of the neurohypophysis. Am J Surg Pathol 24:362–368
4. Burger PC, Scheithauer BW (2007) Tumors of the central ner-
vous system. AFIP Atlas of Tumor Pathology, Series 4, Fascicle
7, Washington
5. Callagy G, Thornton J, Rawluk D, Farrell MA (2000) Benign
glandular peripheral nerve sheath tumor of the seventh and eighth
cranial nerve complex. Clin Neuropathol 19:104–107
6. Casar Borota O, Scheithauer BW, Fougner SL, Hald JK, Ramm-
Pettersen J, Bollerslev J (2009) Spindle cell oncocytoma of the
adenohypophysis: report of a case with marked cellular atypia and
recurrence despite adjuvant treatment. Clin Neuropathol 28:91–95
7. Coire´ CI, Horvath E, Smyth HS, Kovacs K (2009) Rapidly
recurring folliculostellate cell tumor of the adenohypophysis with
the morphology of a spindle cell oncocytoma: case report with
electron microscopic studies. Clin Neuropathol 28:303–308
8. Demssie YN, Joseph J, Dawson T, Roberts G, de Carpentier J,
Howell S (2009) Recurrent spindle cell oncocytoma of the pitu-
itary, a case report and review of the literature. Pituitary doi:
10.1007/s11102-009-0170-6
9. Fuller GN, Scheithauer BW, Roncaroli F, Wesseling P (2007)
Spindle cell oncocytoma. In: Louis DN, Ohgaki H, Wiestler OD,
Cavenee WK (eds) WHO Classification of Tumours of the
Central Nervous System. IARC Lyon, pp 245–246
10. Hampton TA, Scheithauer BW, Rojiani AM, Kovacs K, Horvath
E, Vogt P (1997) Salivary gland-like tumors of the sellar region.
Am J Surg Pathol 21:424–434
11. Hori S, Hayashi N, Fukuoka J, Kurimoto M, Hamada H,
Miyajima K, Nagai S, Endo S (2009) Folliculostellate cell tumor
in pituitary gland. Neuropathology 29:78–80
12. Horvath E, Kovacs K (2002) Folliculo-stellate cells of the human
pituitary: a type of adult stem cell? Ultrastruct Pathol 26:219–228
13. Horvath E, Coire CI, Kovacs K, Smyth HS (2010) Folliculo-
stellate cells of the human pituitary as adult stem cells: examples
of their neoplastic potential. Ultrastruct Pathol 34:133–139
14. Iwaki T, Kondo A, Takeshita I, Nakagaki H, Kitamura K,
Tateishi J (1986) Proliferating potential of folliculo-stellate cells
in human pituitary adenomas. Immunohistochemical and electron
microscopic analysis. Acta Neuropathol 71:233–242
15. Kepes JJ (1978) Transitional cell tumor of the pituitary gland
developing from a Rathke’s cleft cyst. Cancer 41:337–343
16. Kloub O, Perry A, Tu PH, Lipper M, Lopes MBS (2005) Spindle
cell oncocytoma of the adenohypophysis. Report of two recurrent
cases. Am J Surg Pathol 29:247–253
17. Lee EB, Tihan T, Scheithauer BW, Zhang PJ, Gonatas NK (2009)
Thyroid transcription factor 1 expression in sellar tumors: a
histogenetic marker? J Neuropathol Exp Neurol 68:482–488
18. Maartens NF, Ellegally DB, Vance ML, Lopes MBS, Laws ER Jr
(2003) Intrasellar Schwannomas: report of two cases. Neurosur-
gery 52:1200–1206
19. Min HS, Lee SJ, Kim SK, Park SH (2007) Pituitary adenoma with
rich folliculo-stellate cells and mucin-producing epithelia arising
in a 2-year old girl. Pathol Int 57:600–605
20. Nishio S, Mizuno J, Barrow DL, Takei Y, Tindall GT (1987)
Pituitary tumors composed of adenohypophysial adenoma and
Rathke’s cleft cyst elements: a clinicopathological study. Neu-
rosurgery 21:371–377
21. Robinson CA, Curry B, Rewcastle NB (2005) Pseudoglandular
elements in schwannomas. Arch Pathol Lab Med 129:1106–1112
22. Roncaroli F, Scheithauer BW, Cenacchi G, Horvath E, Kovacs K,
Lloyd RV, Abell-Aleff P, Santi M, Yates AJ (2002) ‘‘Spindle cell
oncocytoma’’ of the adenohypophysis. A tumor of folliculostel-
late cells? Am J Surg Pathol 26:1048–1055
23. Scheithauer BW, Kovacs K, Horvath E, Kim DS, Osamura RY,
Ketterling RP, Lloyd RV, Kim OL (2008) Pituitary blastoma.
Acta Neuropathol 116:657–666
24. Scheithauer BW, Swearingen B, Hedley Whyte T, Auluck PK,
Stemmer-Rachamimov AO (2009) Ependymoma of the sella
turcica: a variant of pituicytoma. Hum Pathol 40:435–440
25. Ulm AJ, Yachnis AT, Brat DJ, Rhoton AL (2004) Pituicytoma:
report of two cases and clues regarding histogenesis. Neurosur-
gery 54:753–758
26. Vajtai I, Sahli R, Kappeler A, Christ ER, Seiler RW (2006)
Leiomyomatoid angiomatous neuroendocrine tumor (LANT) of
the pituitary: a distinctive biphasic neoplasm with primitive
secretory phenotype and smooth muscle rich stroma. Acta Neu-
ropathol 111:278–283
27. Vajtai I, von Gunten M, Fung C, Brekenfeld C, Kappeler A,
Reinert MM (2011) Oncocytic ependymoma: A new morpho-
logical variant of high-grade ependymal neoplasm composed of
mitochondrion-rich epithelioid cells. Pathol Res Pract 207:49–54
28. Vogel H, Horoupian DS, Silverberg G (1988) Do folliculo-stel-
late adenomas of the pituitary gland exist or are they intrasellar
meningiomas? Acta Neuropathol 77:219–223
29. Voit D, Saeger W, Ludecke DK (1999) Folliculo-stellate cells in
pituitary adenomas of patients with acromegaly. Pathol Res Pract
195:143–147
30. Woodruff JM, Christensen WN (1993) Glandular peripheral
nerve sheath tumors. Cancer 72:3618–3628
31. Yagishita S, Itoh Y, Nakazima S, Suzuki N, Hirata K, Yamashita
T (1984) Folliculo-stellate cell adenoma of the pituitary. A light
and electron-microscopic study. Acta Neuropathol 62:340–344
258 Acta Neuropathol (2011) 122:253–258
123
